In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HCFA Raising Curtain On PT Self Testing; Roche Bows Out Prior To Showtime

This article was originally published in The Gray Sheet

Executive Summary

HCFA will initiate a national coverage review of home-use prothrombin time tests within the next month, but has not yet determined whether the Medicare Coverage Advisory Committee will be called on for a recommendation on the issue.

You may also be interested in...



Prothrombin Time Self-Tests Gain Support In AHRQ Patient Safety Report

A July 17 Agency for Healthcare Research & Quality report on improving patient safety puts pressure on the Centers for Medicare & Medicaid Services to cover home-use prothrombin time tests on a national basis.

Prothrombin Time Self-Tests Gain Support In AHRQ Patient Safety Report

A July 17 Agency for Healthcare Research & Quality report on improving patient safety puts pressure on the Centers for Medicare & Medicaid Services to cover home-use prothrombin time tests on a national basis.

Prothrombin time tests

HCFA formally opens national coverage review for home-use PT tests Jan. 29. Medicare coverage is currently left to the discretion of the four durable medical equipment regional carriers, which have consistently denied claims (1"The Gray Sheet" Aug. 28, 2000, p. 3). The current review likely will focus on patients with mechanical valves and those with atrial fibrillation who have suffered a cardiovascular event. Comments are due by April 24, 2001

Related Content

UsernamePublicRestriction

Register

MT013782

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel